{"id":15221,"date":"2023-02-01T16:06:34","date_gmt":"2023-02-01T21:06:34","guid":{"rendered":"https:\/\/innovativemedicines.ca\/newsroom\/all-news\/"},"modified":"2023-02-01T16:12:54","modified_gmt":"2023-02-01T21:12:54","slug":"la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes","status":"publish","type":"news","link":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/","title":{"rendered":"La nomination du pr\u00e9sident du CEMPB ouvre la porte \u00e0 un engagement significatif des parties prenantes"},"content":{"rendered":"\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<p><strong>Ottawa, ON<\/strong> \u2013 M\u00e9dicaments novateurs Canada (MNC) accueille la nomination de Thomas Digby au poste de pr\u00e9sident du Conseil d\u2019examen du prix des m\u00e9dicaments brevet\u00e9s (CEPMB).<\/p>\n\n\n\n<p>MNC encourage le CEPMB \u00e0 collaborer avec les parties prenantes des domaines de la sant\u00e9 et des sciences de la vie. Nous nous r\u00e9jouissons de travailler avec M. Digby et ses coll\u00e8gues du conseil d\u2019administration du CEPMB pour nous assurer que les Canadiens ont acc\u00e8s aux nouveaux m\u00e9dicaments lorsqu\u2019ils en ont besoin.<\/p>\n\n\n\n<p><strong>\u00c0 propos de M\u00e9dicaments novateurs Canada<\/strong><\/p>\n\n\n\n<p>M\u00e9dicaments novateurs Canada (MNC) est l\u2019association nationale qui repr\u00e9sente la voix de l\u2019industrie pharmaceutique innovatrice canadienne. L\u2019association d\u00e9fend des politiques qui favorisent la d\u00e9couverte, le d\u00e9veloppement et l\u2019offre de m\u00e9dicaments et de vaccins novateurs afin d\u2019am\u00e9liorer la vie de l\u2019ensemble de la population. De plus, elle soutient l\u2019engagement de ses membres d\u2019\u00eatre des partenaires pr\u00e9cieux du syst\u00e8me de sant\u00e9 canadien. L\u2019association repr\u00e9sente 50 entreprises, qui investissent pr\u00e8s de 1,4 milliard de dollars par an en recherche et d\u00e9veloppement. De cette fa\u00e7on, elle alimente l\u2019\u00e9conomie fond\u00e9e sur la connaissance du pays tout en contribuant \u00e0 hauteur de 8 milliards de dollars \u00e0 l\u2019\u00e9conomie nationale. Tous ses membres suivent le Code d\u2019\u00e9thique de MNC, ils travaillent donc de mani\u00e8re hautement \u00e9thique avec les gouvernements, les payeurs priv\u00e9s, les professionnels de la sant\u00e9 et les parties prenantes.<\/p>\n\n\n\n<p class=\"has-text-align-center\">\u2013 30 \u2013<\/p>\n\n\n\n<p>Pour de plus amples renseignements :<\/p>\n\n\n\n<p>Marise Varanda Directrice, <br \/>Relations avec les m\u00e9dias et contenu <br \/>T\u00e9l\u00e9phone : 613-462-5367 <br \/>Courriel : <a href=\"mailto:media@imc-mnc.ca\">media@imc-mnc.ca<\/a><\/p>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Ottawa, ON \u2013 M\u00e9dicaments novateurs Canada (MNC) accueille la nomination de Thomas Digby au poste de pr\u00e9sident du Conseil d\u2019examen [&hellip;]<\/p>\n","protected":false},"featured_media":15218,"template":"","topic":[245],"team-member-id":[],"news-category":[],"news-tag":[],"class_list":["post-15221","news","type-news","status-publish","has-post-thumbnail","hentry","topic-conseil-dexamen-du-prix-des-medicaments-brevetes-cepmb"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>La nomination du pr\u00e9sident du CEMPB ouvre la porte \u00e0 un engagement significatif des parties prenantes - Innovative Medicines Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La nomination du pr\u00e9sident du CEMPB ouvre la porte \u00e0 un engagement significatif des parties prenantes - Innovative Medicines Canada\" \/>\n<meta property=\"og:description\" content=\"Ottawa, ON \u2013 M\u00e9dicaments novateurs Canada (MNC) accueille la nomination de Thomas Digby au poste de pr\u00e9sident du Conseil d\u2019examen [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovative Medicines Canada\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-01T21:12:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2023\/02\/imc-new-release-feb1-2023.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/\",\"url\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/\",\"name\":\"La nomination du pr\u00e9sident du CEMPB ouvre la porte \u00e0 un engagement significatif des parties prenantes - Innovative Medicines Canada\",\"isPartOf\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2023\/02\/imc-new-release-feb1-2023.jpg\",\"datePublished\":\"2023-02-01T21:06:34+00:00\",\"dateModified\":\"2023-02-01T21:12:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/#primaryimage\",\"url\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2023\/02\/imc-new-release-feb1-2023.jpg\",\"contentUrl\":\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2023\/02\/imc-new-release-feb1-2023.jpg\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"La nomination du pr\u00e9sident du CEMPB ouvre la porte \u00e0 un engagement significatif des parties prenantes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/innovativemedicines.ca\/fr\/#website\",\"url\":\"https:\/\/innovativemedicines.ca\/fr\/\",\"name\":\"Innovative Medicines Canada\",\"description\":\"Transforming Canadians\u2019 lives\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La nomination du pr\u00e9sident du CEMPB ouvre la porte \u00e0 un engagement significatif des parties prenantes - Innovative Medicines Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/","og_locale":"fr_FR","og_type":"article","og_title":"La nomination du pr\u00e9sident du CEMPB ouvre la porte \u00e0 un engagement significatif des parties prenantes - Innovative Medicines Canada","og_description":"Ottawa, ON \u2013 M\u00e9dicaments novateurs Canada (MNC) accueille la nomination de Thomas Digby au poste de pr\u00e9sident du Conseil d\u2019examen [&hellip;]","og_url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/","og_site_name":"Innovative Medicines Canada","article_modified_time":"2023-02-01T21:12:54+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2023\/02\/imc-new-release-feb1-2023.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/","url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/","name":"La nomination du pr\u00e9sident du CEMPB ouvre la porte \u00e0 un engagement significatif des parties prenantes - Innovative Medicines Canada","isPartOf":{"@id":"https:\/\/innovativemedicines.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/#primaryimage"},"image":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/#primaryimage"},"thumbnailUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2023\/02\/imc-new-release-feb1-2023.jpg","datePublished":"2023-02-01T21:06:34+00:00","dateModified":"2023-02-01T21:12:54+00:00","breadcrumb":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/#primaryimage","url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2023\/02\/imc-new-release-feb1-2023.jpg","contentUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2023\/02\/imc-new-release-feb1-2023.jpg","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/la-nomination-du-president-du-cepmb-ouvre-la-porte-a-un-engagement-significatif-des-parties-prenantes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innovativemedicines.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Actualit\u00e9s","item":"https:\/\/innovativemedicines.ca\/fr\/actualites\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/"},{"@type":"ListItem","position":4,"name":"La nomination du pr\u00e9sident du CEMPB ouvre la porte \u00e0 un engagement significatif des parties prenantes"}]},{"@type":"WebSite","@id":"https:\/\/innovativemedicines.ca\/fr\/#website","url":"https:\/\/innovativemedicines.ca\/fr\/","name":"Innovative Medicines Canada","description":"Transforming Canadians\u2019 lives","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news\/15221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media\/15218"}],"wp:attachment":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media?parent=15221"}],"wp:term":[{"taxonomy":"topic","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/topic?post=15221"},{"taxonomy":"team-member-id","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/team-member-id?post=15221"},{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-category?post=15221"},{"taxonomy":"news-tag","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-tag?post=15221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}